The global non-metastatic prostate cancer treatment market is a dynamic sector within the healthcare industry. Driven by an increasing prevalence of prostate cancer, coupled with advancements in diagnostic technologies, this market is poised for significant expansion. Primary players in the market are actively researching new therapies and treatmen